Rapid and selective high-performance liquid chromatographic method for the determination of metronidazole and its active metabolite in human plasma, saliva and gastric juice

J Chromatogr B Biomed Appl. 1996 Mar 3;677(2):374-9. doi: 10.1016/0378-4347(95)00421-1.

Abstract

A rapid and selective HPLC method has been developed for the separation and quantitation of metronidazole and its hydroxylated metabolite in human plasma, saliva and gastric juice. The assay requires a simple protein precipitation step prior to analysis and is selective, sensitive and reproducible. The limits of quantitation (0.5-ml sample) were at least 0.25 microgram/ml for metronidazole and 0.20 micrograms/ml for its hydroxy metabolite. A Hypersil ODS 5 micron (150 x 4.5 mm I.D.) column was used with a mobile phase of acetonitrile-aqueous 0.05 M potassium phosphate buffer (pH 7) containing 0.1 % triethylamine (10:90) delivered at a flow-rate of 1.0 ml/min.

MeSH terms

  • Anti-Infective Agents / blood
  • Anti-Infective Agents / metabolism*
  • Chromatography, High Pressure Liquid / methods*
  • Gastric Juice / metabolism*
  • Humans
  • Metronidazole / analogs & derivatives*
  • Metronidazole / blood
  • Metronidazole / metabolism*
  • Reference Standards
  • Reproducibility of Results
  • Saliva / metabolism*
  • Sensitivity and Specificity
  • Spectrophotometry, Ultraviolet
  • Tinidazole / blood
  • Tinidazole / metabolism

Substances

  • Anti-Infective Agents
  • Tinidazole
  • Metronidazole
  • 1-(2-hydroxyethyl)-2-hydroxymethyl-5-nitroimidazole